rs2244613
From SNPedia
| Orientation | minus |
| Stabilized | minus |
| Make rs2244613(A;A) |
| Make rs2244613(A;C) |
| Make rs2244613(C;C) |
| Reference | GRCh37.p5 37.3/137 |
| Chromosome | 16 |
| Position | 55810697 |
| Gene | CES1 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2244613 |
| dbSNP (classic) | rs2244613 |
| ClinGen | rs2244613 |
| ebi | rs2244613 |
| HLI | rs2244613 |
| Exac | rs2244613 |
| Gnomad | rs2244613 |
| Varsome | rs2244613 |
| LitVar | rs2244613 |
| Map | rs2244613 |
| PheGenI | rs2244613 |
| Biobank | rs2244613 |
| 1000 genomes | rs2244613 |
| hgdp | rs2244613 |
| ensembl | rs2244613 |
| geneview | rs2244613 |
| scholar | rs2244613 |
| rs2244613 | |
| pharmgkb | rs2244613 |
| gwascentral | rs2244613 |
| openSNP | rs2244613 |
| 23andMe | rs2244613 |
| SNPshot | rs2244613 |
| SNPdbe | rs2244613 |
| MSV3d | rs2244613 |
| GWAS Ctlg | rs2244613 |
| GMAF | 0.3081 |
| Max Magnitude | 0 |
| GWAS snp | |
|---|---|
| PMID | [PMID 23467860] |
| Trait | Response to dabigatran etexilate treatment |
| Title | Genetic determinants of dabigatran plasma levels and their relation to bleeding. |
| Risk Allele | |
| P-val | 5E-7 |
| Odds Ratio | 1.16 [1.10-1.22] |
[PMID 27261537] Pharmacogenetics of dabigatran etexilate interindividual variability.
[PMID 25611302
] OATP1B1 and tumour OATP1B3 modulate exposure, toxicity, and survival after irinotecan-based chemotherapy
[PMID 33179295] The impact of ABCB1 and CES1 polymorphisms on dabigatran pharmacokinetics and pharmacodynamics in patients with atrial fibrillation.
